Cargando…
Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short?
Autores principales: | Leath, Charles A., Hamilton, Chad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710552/ https://www.ncbi.nlm.nih.gov/pubmed/31467963 http://dx.doi.org/10.1016/j.gore.2019.07.004 |
Ejemplares similares
-
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018) -
Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020) -
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
por: Chambers, Laura M., et al.
Publicado: (2022) -
Response to “surgical management of cervical cancer by laparoscopy or laparotomy”
por: Leath, Charles A., et al.
Publicado: (2018)